Christine Cournoyer - 12 May 2025 Form 4 Insider Report for CareDx, Inc. (CDNA)

Reporting relationship: Director
Issuer ticker: CDNA
Reported as of: 12 May 2025
Net transaction value: -$233,100
SEC form: 4
Accepted by SEC: 14 May 2025, 17:18:54 UTC
Prior SEC filing: 12 May 2025
Next SEC filing: 17 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Christine Cournoyer

Key filing fact

Christine Cournoyer filed Form 4 for CareDx, Inc. (CDNA) on 14 May 2025.

Key facts

This page summarizes Christine Cournoyer's Form 4 filing for CareDx, Inc. (CDNA).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 May 2025, 17:18.

Change

Previous filing in this sequence was filed on 12 May 2025.
Current net transaction value: -$233,100.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001180466 Primary reporting owner

COURNOYER CHRISTINE

Relationship: Director
Address: C/O CAREDX, INC., 8000 MARINA BOULEVARD, BRISBANE
Signature: /s/ Christine Cournoyer
Signature date: 14 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDNA transaction

Common Stock

Options Exercise

Transaction value: $231,923
Shares: +29,136
Change %: +79%
Price: $7.96
Shares after: 66,181
Date: 12 May 2025
Ownership: Direct

CDNA transaction

Common Stock

Sale

Transaction value: $465,022
Shares: -29,136
Change %: -44%
Price: $15.96
Shares after: 37,045
Date: 12 May 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDNA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -29,136
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 12 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 29,136
Exercise price: $7.96
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.95 to $15.98, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Footnote F2

The shares subject to this option vested fully on June 16, 2024.